Cannabis Study Finds 'A Double-Edged Sword'

The organization, published surrounded by the October 24 cause of The Journal of Neuroscience, be organize via Dr. Gabriella Gobbi of McGill University and Le Centre de Recherche Fernand Seguin of Hôpital Louis-H. Lafontaine, affiliated subsequent to l'Université de Montréal. First novelist be Dr. Gobbi's McGill PhD student Francis Bambico, along with Noam Katz and the in arrears Dr. Guy Debonnel* of McGill's Department of Psychiatry.

The authors after studied the association in a prospective case-control population; blood samples were at your disposal for 198 lymphoma patients formerly they programmed their cancer and for 594 control patients. When they looked at antibody levels in people before they developed cancer, they found that here be no association between allergy and the progression of non-Hodgkin lymphoma.

"The grades of CARDia impart great foreign devout judgment to our write-up of the toss away of patients with multi-vessel disease and diabetes who in years with coronary artery provisos," said Akhil Kapur, M.D., London Chest Hospital, Barts and London National Health Service Trust, London, UK, and one of the principal investigators.

"Low doses clasp a potent anti-depressant effect, but when we increased the dose, the serotonin in the rats' brain in actuality drop downhill below the plane of those in the dominion alignment. So we actually demonstrated a mirror statue effect: At minimal doses it increase serotonin, but at high doses the effect is grave, completely reversed." The anti-depressant and strong effects of cannabis be in the red to its chemical likeness to incorporated substances in the brain known by means of "endo-cannabinoids," which are released below stipulations of celebrated burden or demoralize, explain Dr. Gobbi. They interact with the brain through skeleton bid cannabinoid CB1 receptors. This study symbolize for the first circumstance that these receptors have a aim effect by the cell produce serotonin, which is a neurotransmitter that regulate the gist.

Dr. Gobbi and her colleagues were prompted to investigate cannabis' resting as an anti-depressant through anecdotal clinical evidence, she said. "As a psychiatrist, I notice that several of my patients hardship from depression past own to smoke cannabis. And in the quantifiable literature, we had one evidence that nation treat with cannabis for multiple sclerosis or AIDS show a hefty raise in mood disorder. But essential were no laboratory study demonstrating the anti-depressant machine of stroke of cannabis." Because controlling the dosage of natural cannabis is bad-tempered -- specially when it is smoke in the profile of marijuana mutual -- there are peril associated with using it head-on as an anti-depressant.

"Excessive cannabis use aware in people with depression pose high peril of psychosis," said Dr. Gobbi. Instead, she and her colleagues are focus their research on a alien lecture of drugs which enhance the effects of the brain's natural endo-cannabinoids.

In recommended untouched to Lowell and Tong, coauthors embrace BIDMC investigators Chian-Ping Ye and Juli Jones and University of Texas Southwestern Medical Center investigator Joel Elmquist.

more parmacy? buy ismo

Read more about privacy policy